
	June 3, 2008

Now Available:
Download the podcast of Dr. Olech's presentation

With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.

MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

MSK Video Report:

Dr. Ewa Olech presents "eMRI in Clinical Practice: A Rheumatologist's Perspective" at the ISEMIR Conference

Arthritis: Texas, New Jersey Appeals Overturn Nearly $40 Million in Vioxx Awards
Merck won two major appeals court cases involving older Vioxx cases this week...

Arthritis: Rituximab May Be First Choice Biologic for Some RA Patients
Rituximab may be a reasonable first-line biologic choice for rheumatoid arthritis (RA) patients who are not candidates for tumor necrosis factor ¦Á (TNF) blockers...

Consumer News: 3 Years Later, Knees Made for Dancing
Patients need to be better educated and given greater support before and after total knee replacement surgery...

BioPharm Business: Osteologix Reports Additional Positive Phase II Data for NB S101 (strontium malonate) for Osteoporosis
Osteologix reported that the osteoporosis drug candidate was well-tolerated and significantly suppressed bone resorption while simultaneously improving bone mineral density (BMD) at 12 weeks...

BioPharm Business: Targeted Genetics Reports Positive Interim Findings From Inflammatory Arthritis Phase I/II Trial of tgAAC94; Demonstrates Safety and Preliminary Efficacy, Supports Further Clinical Development
Targeted Genetics Corp's study is designed to assess the safety and potential effect of multiple doses of tgAAC94 administered directly to affected joints of inflammatory arthritis subjects with or without concurrent use of systemic TNF antagonist therapies...